Skip to content

Rapid Micro Biosystems RPID Total Liabilities

Total Liabilities at other companies

Charles River Laboratories logo
Charles River LaboratoriesCRL
$30M-99.3%
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO
$2.94B+3.2%
Pacific Biosciences of California logo
Pacific Biosciences of CaliforniaPACB
$780M
iRadimed logo
iRadimedIRMD
$15.88M+36.0%
Ginkgo Bioworks logo
Ginkgo BioworksDNA
$5.69M-34.0%
West Pharmaceutical Services logo
West Pharmaceutical ServicesWST
$16.6M-31.4%

Other financials

Income statement

See full
Revenue$8.0M+11.1%
Gross profit$371.0K-8.2%
Operating income-$13.9M-18.8%
Net income-$14.3M-26.7%
EPS (diluted)-$0.31-19.2%

Balance sheet

See full
Cash & equivalents$14.1M-26.8%
Total debt$23.8M+301%
Total equity$20.4M-68.9%
Total assets$62.4M-27.0%

Cash flow

See full
Operating cash flow-$15.1M-66.1%
CapEx$394.0K+23.5%
Free cash flow-$15.5M-64.7%

Valuation

See full
Market cap$86.19M-43.8%
Enterprise value$95.86M-31.7%
P/S2.5×-2.6×

Profitability

See full
Operating margin-144.2%-12.7pp
Net margin-145.8%-5.0pp
FCF margin-110.5%-14.9pp

Returns & leverage

See full
Return on equity-116.7%-620pp
Debt / equity1.2×+1.1×
Current ratio2.6×-2.0×

Where this comes from

Reported directly by Rapid Micro Biosystems in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: Rapid Micro Biosystems’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about Rapid Micro Biosystems's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Rapid Micro Biosystems's total liabilities?
Rapid Micro Biosystems (RPID) reported total liabilities of $41.97M in Q1 2026.
How has Rapid Micro Biosystems's total liabilities changed year-over-year?
Rapid Micro Biosystems's total liabilities increased by 110.4% year-over-year, from $19.94M to $41.97M.
What is the long-term trend for Rapid Micro Biosystems's total liabilities?
Over 5 years (2020 to 2025), Rapid Micro Biosystems's total liabilities has grown at a -1.6% compound annual growth rate (CAGR), from $45.18M to $41.65M.
What does total liabilities mean?
The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.